Summary:
A Double-Blind placebo controlled study assessing study medication use to prevent first major cardiovascular events in participants with elevated Lipoprotein(a)
Qualified Participants Must:
Must have two of the following risk factors:
- Age greater than 65
- History of hypertension
- Current smoker
- Have Diabetes type 1 or 2, kidney disease, familial history of hypercholesterolemia, Coronary artery disease
Qualified Participants May Receive:
Compensation for participation if qualified
Consultation with a Physician